Digestive System Neoplasms
"Digestive System Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the DIGESTIVE SYSTEM.
| Descriptor ID |
D004067
|
| MeSH Number(s) |
C04.588.274 C06.301
|
| Concept/Terms |
Digestive System Neoplasms- Digestive System Neoplasms
- Digestive System Neoplasm
- Neoplasm, Digestive System
- Neoplasms, Digestive System
Cancer of Digestive System- Cancer of Digestive System
- Digestive System Cancers
- Digestive System Cancer
- Cancer, Digestive System
- Cancers, Digestive System
- Cancer of the Digestive System
|
Below are MeSH descriptors whose meaning is more general than "Digestive System Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Digestive System Neoplasms".
This graph shows the total number of publications written about "Digestive System Neoplasms" by people in this website by year, and whether "Digestive System Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Digestive System Neoplasms" by people in Profiles.
-
Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 2021 03; 17(3):e1009254.
-
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185.
-
Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):90-98.
-
Screening for malignancy in primary sclerosing cholangitis (PSC). Curr Gastroenterol Rep. 2015 Apr; 17(4):17.
-
The effect of a regional hepatopancreaticobiliary surgical program on clinical volume, quality of cancer care, and outcomes in the Veterans Affairs system. JAMA Surg. 2014 Nov; 149(11):1153-61.
-
Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience. Pancreas. 2014 May; 43(4):518-25.
-
Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28]. Urol Oncol. 2013 Jul; 31(5):716.
-
Cancer risk related to gastrointestinal diagnostic radiation exposure. Curr Gastroenterol Rep. 2011 Oct; 13(5):449-57.
-
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. J Natl Compr Canc Netw. 2009 Jul; 7(7):712-47.
-
Utility of the FIESTA pulse sequence in body oncologic imaging: review. AJR Am J Roentgenol. 2009 Jun; 192(6 Suppl):S83-93 (Quiz S94-7).